Cart
sales@molnova.com
CDD3505
CAS No. 173865-33-3
CDD3505( 4-nitro-1-trityl-1H-imidazole )
Catalog No. M26553 CAS No. 173865-33-3
CDD3505 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 32 | In Stock |
|
| 5MG | 30 | In Stock |
|
| 10MG | 51 | In Stock |
|
| 25MG | 90 | In Stock |
|
| 50MG | 129 | In Stock |
|
| 100MG | 193 | In Stock |
|
| 200MG | 290 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCDD3505
-
NoteResearch use only, not for human use.
-
Brief DescriptionCDD3505 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.
-
DescriptionCDD3505 increases high-density lipoprotein cholesterol by targeting hepatic CYP3A.
-
In VitroCDD3505 specifically induces hepatic cytochrome P450IIIA produces significant increases in HDL cholesterol.
-
In Vivo——
-
Synonyms4-nitro-1-trityl-1H-imidazole
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorAnti-infection| Bacterial| HIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number173865-33-3
-
Formula Weight355.397
-
Molecular FormulaC22H17N3O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 14.29 mg/mL (40.21 mM)
-
SMILES[O-][N+](=O)c1cn(cn1)C(c1ccccc1)(c1ccccc1)c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Chaudhuri S, et al. Binding of the bioflavonoid robinetin with model membranes and hemoglobin: Inhibition of lipid peroxidation and protein glycosylation. J Photochem Photobiol B. 2010 Jan 21;98(1):12-9.
molnova catalog
related products
-
Pradefovir mesylate
Pradefovir mesylate is converted to 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in human liver microsomes with Km of 60 μM.
-
TAK-700 (Orteronel)
Orteronel(TAK-700) was selected as a candidate for clinical evaluation.
-
CYP1B1-IN-4
CYP1B1-IN-4, a 2,4-diarylthiazole compound, exhibits selective inhibition of CYP1B1 (IC50=0.2 nM), demonstrating minimal cytotoxicity and high stability in human and rat liver microsomes .
